Clinical Trial Update: A Study of Thymoglobulin and Tacrolimus in Liver Transplant [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial evaluating thymoglobulin with tacrolimus for immunosuppression in liver transplant recipients; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Disease

Drugs mentioned

• Tacrolimus (Tacrolimus)
• Thymoglobulin (rabbit anti-thymocyte globulin)

Snippet

Sponsor: University of Nebraska | Conditions: Liver Transplantation, Liver Disease | Phase 4 | Status: UNKNOWN